Gastroenterology and gastrointestinal endoscopy under SARS-CoV-2 pandemic conditions
Letters to editorGastroent Hepatol 2020; 74(2): 163–164. doi:10.14735/amgh2020163
Literaturepdf Ilja TachecíAnderson-Fabry disease and gastrointestinal tract involvement
Case reportGastroent Hepatol 2020; 74(2): 158–162. doi:10.14735/amgh2020158
SummaryLiteraturepdf Gabriela Dostálová, Lenka Roblová, Petra Reková, Josef Marek, Ondřej Kodet, Zora Dubská, Aleš Linhart, Daniel RobRecommendations of the Slovak IBD Working Group on SGS for the Treatment of Biosimilar Anti-TNF Biologics in Adult and Pediatric Patients
GuidelinesGastroent Hepatol 2020; 74(2): 130–134. doi:10.14735/amgh2020130
Literaturepdf Barbora Kadlečková, Igor Šturdík, Peter Lietava, Laura Gombošová, Iveta Čierna, Tibor Hlavatý, Martin HuorkaDoporučení pro léčbu idiopatických střevních zánětů v době pandemie covid-19
GuidelinesGastroent Hepatol 2020; 74(2): 123–129. doi:10.14735/amgh2020123
Milan Lukáš, Pracovní skupina pro idiopatické střevní záněty ČGS ČLS JEPDe novo non-alcoholic fatty liver disease after liver transplantation – as diagnosed by magnetic resonance
Original articleGastroent Hepatol 2020; 74(2): 116– 122. doi:10.14735/amgh2020116
SummaryLiteraturepdf Ľubomír Skladaný, Svetlana Adamcová-Selčanová, Jana Čiefová, Natalia Bystrianska, Beata Škvarková, Beata Bachová, Tomáš KollerInfection in patients hospitalised with advanced chronic liver disease (cirrhosis) – single-centre experience
Original articleGastroent Hepatol 2020; 74(2): 111–115. doi:10.14735/amgh2020111
SummaryLiteraturepdf Natalia Bystrianska, Ľubomír Skladaný, Svetlana Adamcová-Selčanová, Tomáš Koller, Daniela Janceková , Jana VnenčákováGuideline of the Czech Hepatology Society of the ČLS JEP for diagnosis and treatment of non-alcoholic fatty liver disease
GuidelinesGastroent Hepatol 2020; 74(2): 103–110. doi:10.14735/amgh2020103
Literaturepdf Radan Brůha, Karel Dvořák, Tomáš Fejfar, Václav Šmíd, Pavel TrunečkaAllogeneic, mesenchymal stem cells (ALOFISEL) are effective in eradicating complex peri-anal fistulas in Crohn’s disease
Drug profileGastroent Hepatol 2019; 73(6): 553–554. doi:10.14735/amgh2019553
Literaturepdf Milan LukášAnti-TNF alpha-induced immune-mediated skin adverse reactions resolved by switching to ustekinumab
Case reportGastroent Hepatol 2019; 73(6): 496–500. doi:10.14735/amgh2019496
SummaryLiteraturepdf Karolína Vorčáková, Marta Horáková, Juraj Péč